{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T15:56:36Z","timestamp":1776959796068,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","issue":"31","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["19QB1406600"],"award-info":[{"award-number":["19QB1406600"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.vaccine.2021.06.031","type":"journal-article","created":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T07:38:29Z","timestamp":1624261109000},"page":"4296-4305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Preclinical evaluation of recombinant HFMD vaccine based on enterovirus 71 (EV71) virus-like particles (VLP): Immunogenicity, efficacy and toxicology"],"prefix":"10.1016","volume":"39","author":[{"given":"Ziyan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenliang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianjun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6561-7269","authenticated-orcid":false,"given":"Yuanxiang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinxing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yalin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Likang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baofeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianzhong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qunying","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ge","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2021.06.031_b0005","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.virol.2020.06.011","article-title":"Global profiling of the alternative splicing landscape reveals transcriptomic diversity during the early phase of enterovirus 71 infection","volume":"548","author":"Li","year":"2020","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2021.06.031_b0010","doi-asserted-by":"crossref","unstructured":"Haaheim LR, Pattison JR, Whitley RJ. A Practical Guide to Clinical Virology || Enteroviruses: Polioviruses, Coxsackieviruses, Echoviruses and Newer Enteroviruses. 2002;10.1002\/0470857285:44-5. https:\/\/doi.org\/10.1002\/0470857285.ch6.","DOI":"10.1002\/0470857285.ch6"},{"key":"10.1016\/j.vaccine.2021.06.031_b0015","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1473-3099(13)70342-6","article-title":"Hand, foot, and mouth disease in China, 2008\u201312: an epidemiological study","volume":"14","author":"Xing","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2021.06.031_b0020","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1574-6976.2002.tb00601.x","article-title":"An overview of the evolution of enterovirus 71 and its clinical and public health significance","volume":"26","author":"McMinn","year":"2002","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.vaccine.2021.06.031_b0025","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0168-1702(95)00087-9","article-title":"Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus","volume":"39","author":"Brown","year":"1995","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2021.06.031_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vaccine.2019.09.111","article-title":"Establishment of Asia-Pacific Network for Enterovirus Surveillance","volume":"38","author":"Chiu","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.06.031_b0035","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1517\/14712598.2014.935330","article-title":"Update on the development of enterovirus 71 vaccines","volume":"14","author":"Kung","year":"2014","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.vaccine.2021.06.031_b0040","unstructured":"WPRO | A Guide to Clinical Management and Public Health Response for Hand, Foot and Mouth disease (HFMD). WPRO | WHO Western Pacific Region. https:\/\/iris.wpro.who.int\/bitstream\/handle\/10665.1\/5521\/9789290615255_eng.pdf."},{"key":"10.1016\/j.vaccine.2021.06.031_b0045","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/infdis\/129.3.304","article-title":"An apparently new enterovirus isolated from patients with disease of the central nervous system","volume":"129","author":"Schmidt","year":"1974","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2021.06.031_b0050","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.micinf.2010.03.006","article-title":"Neural pathogenesis of enterovirus 71 infection","volume":"12","author":"Weng","year":"2010","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2021.06.031_b0055","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.bbrc.2012.11.035","article-title":"Recombinant VP1 protein expressed in Pichia pastoris induces protective immune responses against EV71 in mice","volume":"430","author":"Wang","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.vaccine.2021.06.031_b0060","doi-asserted-by":"crossref","first-page":"e1737","DOI":"10.1371\/journal.pntd.0001737","article-title":"Challenges to licensure of enterovirus 71 vaccines","volume":"6","author":"Lee","year":"2012","journal-title":"PLoS Negl Trop Dis."},{"key":"10.1016\/j.vaccine.2021.06.031_b0065","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nsmb.2255","article-title":"A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71","volume":"19","author":"Wang","year":"2012","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.vaccine.2021.06.031_b0070","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1016\/j.vaccine.2011.04.010","article-title":"Identification and characterization of a cross-neutralization epitope of Enterovirus 71","volume":"29","author":"Liu","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.06.031_b0075","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1128\/JVI.01019-09","article-title":"Evolutionary genetics of human enterovirus 71: origin, population dynamics, natural selection, and seasonal periodicity of the VP1 gene","volume":"84","author":"Tee","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2021.06.031_b0080","doi-asserted-by":"crossref","first-page":"e90624","DOI":"10.1371\/journal.pone.0090624","article-title":"Molecular comparison and evolutionary analyses of VP1 nucleotide sequences of new African human enterovirus 71 isolates reveal a wide genetic diversity","volume":"9","author":"Bessaud","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2021.06.031_b0085","doi-asserted-by":"crossref","first-page":"5803","DOI":"10.1128\/JVI.00289-14","article-title":"Attenuation of human enterovirus 71 high-replication-fidelity variants in AG129 mice","volume":"88","author":"Meng","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2021.06.031_b0090","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1303224","article-title":"An inactivated enterovirus 71 vaccine in healthy children","volume":"370","author":"Li","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2021.06.031_b0095","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1586\/14760584.2016.1138862","article-title":"EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD)","volume":"15","author":"Mao","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2021.06.031_b0100","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1080\/21645515.2015.1115934","article-title":"Comprehensive safety assessment of a human inactivated diploid enterovirus 71 vaccine based on a phase III clinical trial","volume":"12","author":"Zhang","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2021.06.031_b0105","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa1304923","article-title":"Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China","volume":"370","author":"Zhu","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2021.06.031_b0110","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/infdis\/jiw502","article-title":"2-Year Efficacy, Immunogenicity, and Safety of Vigoo Enterovirus 71 Vaccine in Healthy Chinese Children: A Randomized Open-Label Study","volume":"215","author":"Wei","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2021.06.031_b0115","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1080\/21645515.2018.1442997","article-title":"Five-year immunity persistence following immunization with inactivated enterovirus 71 type (EV71) vaccine in healthy children: a further observation","volume":"14","author":"Hu","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2021.06.031_b0120","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1080\/21645515.2015.1053675","article-title":"Immunogenicity and protective efficacy of an EV71 virus-like particle vaccine against lethal challenge in newborn mice","volume":"11","author":"Sun","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2021.06.031_b0125","doi-asserted-by":"crossref","first-page":"e0003692","DOI":"10.1371\/journal.pntd.0003692","article-title":"Recombinant adeno-vaccine expressing enterovirus 71-like particles against hand, foot, and mouth disease","volume":"9","author":"Tsou","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2021.06.031_b0130","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.virusres.2006.12.005","article-title":"Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides","volume":"125","author":"Foo","year":"2007","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2021.06.031_b0135","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1016\/j.vaccine.2016.02.077","article-title":"Status of research and development of vaccines for enterovirus 71","volume":"34","author":"Reed","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.06.031_b0140","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1080\/14760584.2016.1191357","article-title":"Enterovirus 71: a whole virion inactivated enterovirus 71 vaccine","volume":"15","author":"Zhou","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2021.06.031_b0145","doi-asserted-by":"crossref","first-page":"e0210477","DOI":"10.1371\/journal.pone.0210477","article-title":"Efficient expression of enterovirus 71 based on virus-like particles vaccine","volume":"14","author":"Kim","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2021.06.031_b0150","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1586\/erv.10.115","article-title":"Virus-like particles in vaccine development","volume":"9","author":"Roldao","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2021.06.031_b0155","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.vaccine.2012.10.083","article-title":"Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development","volume":"31","author":"Kushnir","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.06.031_b0160","doi-asserted-by":"crossref","first-page":"e57601","DOI":"10.1371\/journal.pone.0057601","article-title":"Neutralizing antibodies induced by recombinant virus-like particles of enterovirus 71 genotype C4 inhibit infection at pre- and post-attachment steps","volume":"8","author":"Ku","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2021.06.031_b0165","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.1007\/s00253-014-5732-5","article-title":"Protein expression in Pichia pastoris: recent achievements and perspectives for heterologous protein production","volume":"98","author":"Ahmad","year":"2014","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.vaccine.2021.06.031_b0170","article-title":"Development and characterization of an enterovirus 71 (EV71) virus-like particles (VLPs) vaccine produced in Pichia pastoris","volume":"1\u20139","author":"Yang","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2021.06.031_b0175","doi-asserted-by":"crossref","first-page":"e64116","DOI":"10.1371\/journal.pone.0064116","article-title":"Development and evaluation of a pseudovirus-luciferase assay for rapid and quantitative detection of neutralizing antibodies against enterovirus 71","volume":"8","author":"Wu","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2021.06.031_b0180","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.yrtph.2007.05.005","article-title":"Pre-clinical safety evaluation of heat shock protein 65-MUC1 peptide fusion protein","volume":"49","author":"Huo","year":"2007","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.vaccine.2021.06.031_b0185","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0300-483X(02)00055-0","article-title":"Non-clinical vaccine safety assessment","volume":"174","author":"Verdier","year":"2002","journal-title":"Toxicology"},{"key":"10.1016\/j.vaccine.2021.06.031_b0190","doi-asserted-by":"crossref","first-page":"4","DOI":"10.7774\/cevr.2017.6.1.4","article-title":"Enterovirus 71 infection and vaccines","volume":"6","author":"Yi","year":"2017","journal-title":"Clin Exp Vaccine Res"},{"key":"10.1016\/j.vaccine.2021.06.031_b0195","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10096-018-3206-x","article-title":"Hand, foot and mouth disease: current knowledge on clinical manifestations, epidemiology, aetiology and prevention","volume":"37","author":"Esposito","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2021.06.031_b0200","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.vaccine.2011.12.081","article-title":"Enterovirus type 71 neutralizing antibodies in the serum of macaque monkeys immunized with EV71 virus-like particles","volume":"30","author":"Lin","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.06.031_b0205","doi-asserted-by":"crossref","first-page":"e21757","DOI":"10.1371\/journal.pone.0021757","article-title":"Display of VP1 on the surface of baculovirus and its immunogenicity against heterologous human enterovirus 71 strains in mice","volume":"6","author":"Meng","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2021.06.031_b0210","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1586\/14760584.3.2.119","article-title":"Recombivax-HB: perspectives past, present and future","volume":"3","author":"Venters","year":"2004","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2021.06.031_b0215","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1186\/gb-2011-12-7-r63","article-title":"Genome sequence and global sequence variation map with 5.5 million SNPs in Chinese rhesus macaque","volume":"12","author":"Fang","year":"2011","journal-title":"Genome Biol."},{"key":"10.1016\/j.vaccine.2021.06.031_b0220","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1126\/science.1139247","article-title":"Evolutionary and biomedical insights from the rhesus macaque genome","volume":"316","author":"Rhesus Macaque Genome","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2021.06.031_b0225","doi-asserted-by":"crossref","first-page":"6290","DOI":"10.1016\/j.vaccine.2015.09.047","article-title":"Similar protective immunity induced by an inactivated enterovirus 71 (EV71) vaccine in neonatal rhesus macaques and children","volume":"33","author":"Zhang","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.06.031_b0230","first-page":"6917","article-title":"Immunogenicity and safety of a recombinant vaccinia virus vaccine expressing the carcinoembryonic antigen gene in a nonhuman primate","volume":"52","author":"Kantor","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/j.vaccine.2021.06.031_b0235","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/infdis\/167.3.553","article-title":"A human respiratory syncytial virus (RSV) primate model of enhanced pulmonary pathology induced with a formalin-inactivated RSV vaccine but not a recombinant FG subunit vaccine","volume":"167","author":"Kakuk","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2021.06.031_b0240","doi-asserted-by":"crossref","first-page":"6269","DOI":"10.1016\/j.vaccine.2011.06.044","article-title":"Immunoprotection elicited by an enterovirus type 71 experimental inactivated vaccine in mice and rhesus monkeys","volume":"29","author":"Dong","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.06.031_b0245","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1586\/14760584.4.6.855","article-title":"Ensuring the quality, potency and safety of vaccines during preclinical development","volume":"4","author":"Lebron","year":"2005","journal-title":"Expert Rev Vaccines"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21007672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21007672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:58:53Z","timestamp":1759402733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21007672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":49,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0264410X21007672"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.06.031","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical evaluation of recombinant HFMD vaccine based on enterovirus 71 (EV71) virus-like particles (VLP): Immunogenicity, efficacy and toxicology","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.06.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}